Cargando…
CD47 blockade inhibits tumor progression human osteosarcoma in xenograft models
Osteosarcoma is the most common bone tumors in children and adolescents. Despite intensive chemotherapy, patients with advanced disease still have a poor prognosis, illustrating the need for alternative therapies. In this study, we explored the use of antibodies that block CD47 with a tumor growth s...
Autores principales: | Xu, Ji-Feng, Pan, Xiao-Hong, Zhang, Shui-Jun, Zhao, Chen, Qiu, Bin-Song, Gu, Hai-Feng, Hong, Jian-Fei, Cao, Li, Chen, Yu, Xia, Bing, Bi, Qin, Wang, Ya-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695143/ https://www.ncbi.nlm.nih.gov/pubmed/26093091 |
Ejemplares similares
-
Synergistic effect of CD47 blockade in combination with cordycepin treatment against cancer
por: Feng, Chen, et al.
Publicado: (2023) -
Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells
por: Candas-Green, Demet, et al.
Publicado: (2020) -
CD47 Blockade Triggers T cell-mediated Destruction of Immunogenic Tumors
por: Liu, Xiaojuan, et al.
Publicado: (2015) -
A Novel Blockade CD47 Antibody With Therapeutic Potential for Cancer
por: Lin, Fangzhen, et al.
Publicado: (2021) -
CD47 blockade enhances phagocytosis of cardiac cell debris by neutrophils
por: Haj-Yehia, Elias, et al.
Publicado: (2023)